Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir

被引：13

作者：

Fellay, J ^{[1
]}

Venetz, JP

Pascual, M

Aubert, JD

Seydoux, C

Meylan, PR

机构：

[1] CHU Vaudois, Ctr Transplantat, CH-1011 Lausanne, Switzerland

[2] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland

[3] CHU Vaudois, Serv Malad Infect, CH-1011 Lausanne, Switzerland

[4] CHU Vaudois, Serv Pneumol, CH-1011 Lausanne, Switzerland

[5] CHU Vaudois, Serv Cardiol, CH-1011 Lausanne, Switzerland

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷 / 07期

关键词：

D O I：

10.1111/j.1600-6143.2005.00936.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：1781 / 1782

页数：2

共 7 条

[1] Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: A single center experience [J].

Babel, N ;

Gabdrakhmanova, L ;

Juergensen, JS ;

Eibl, N ;

Hoerstrup, J ;

Hammer, M ;

Rosenberger, C ;

Hoeflich, C ;

Frei, U ;

Rohde, F ;

Volk, HD ;

Reinke, P .

TRANSPLANTATION, 2004, 78 (02) :283-285

[2]

Kudlacz E, 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x

[3] A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. [J].

Martin, DF ;

Sierra-Madero, J ;

Walmsley, S ;

Wolitz, RA ;

Macey, K ;

Georgiou, P ;

Robinson, CA ;

Stempien, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1119-1126

[4] Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir [J].

Mattes, FM ;

Hainsworth, EG ;

Hassan-Walker, AF ;

Burroughs, AK ;

Sweny, P ;

Griffiths, PD ;

Emery, VC .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (01) :89-92

[5] Determinants of protracted cytomegalovirus infection in solid-organ transplant patients [J].

Muheim, C ;

Vogel, G ;

Seydoux, C ;

Gillet, M ;

Mosimann, F ;

Von Segesser, L ;

Sahli, R ;

Estrade, C ;

van Melle, G ;

Meylan, PRA .

TRANSPLANTATION, 2002, 74 (02) :226-236

[6] Canadian Society of Transplantation Consensus Workshop on Cytomegalovirus Management in solid organ transplantation final report [J].

Preiksaitis, JK ;

Brennan, DC ;

Fishman, J ;

Allen, U .

AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (02) :218-227

[7] Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts [J].

Reusser, P .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (09) :1745-1753

← 1 →